Sept 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Adapthealth, Carnival and Phunware, on Monday.
HIGHLIGHTS
* Adapthealth Corp AHCO.O: Leerink Partners cuts target price to $13 from $14 |
* Ardent Health Partners Inc ARDT.N: JP Morgan raises target price to $19 from $18 |
* Carnival Corp CCL.N: HSBC raises target price to $14 from $13 |
* Miniso Group Holding Ltd MNSO.N: JP Morgan cuts target price to $27 from $29 |
* Phunware Inc PHUN.O: Ascendiant Capital Markets cuts target price to $20 from $22 |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* Adapthealth Corp AHCO.O: Leerink Partners cuts target price to $13 from $14 |
* Aemetis Inc AMTX.O: Ascendiant Capital Markets cuts target price to $19 from $20 |
* Aerovironment Inc AVAV.O: RBC raises target price to $230 from $200 |
* Aim Immunotech Inc AIM.A: Ascendiant Capital Markets cuts PT to $5 from $5.25 |
* Ardent Health Partners Inc ARDT.N: JP Morgan raises target price to $19 from $18 |
* Carnival Corp CCL.N: HSBC raises target price to $14 from $13 |
* CF Industries Holdings Inc CF.N: Berenberg raises target price to $69 from $67 |
* Ferrari RACE.N: Bernstein raises target price to $599 from $488 |
* IGC Pharma Inc IGC.A: Ascendiant Capital Markets raises PT to $3.75 from $3.5 |
* Miniso Group Holding Ltd MNSO.N: JP Morgan cuts target price to $27 from $29 |
* Outlook Therapeutics Inc OTLK.O: Ascendiant Capital Markets cuts PT to $33 from $35 |
* Phunware Inc PHUN.O: Ascendiant Capital Markets cuts target price to $20 from $22 |
* Plus Therapeutics Inc PSTV.O: Ascendiant Capital Markets cuts PT to $20 from $21 |
* T-Mobile TMUS.O: Bernstein raises target price to $220 from $190 |
(Compiled by Bengaluru Newsroom)